SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-000922
Filing Date
2012-01-06
Accepted
2012-01-06 17:21:48
Documents
6
Period of Report
2012-01-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-2256_18k.htm 8-K 34152
2 EX-10.1 a12-2256_1ex10d1.htm EX-10.1 36171
3 EX-99.1 a12-2256_1ex99d1.htm EX-99.1 19709
4 GRAPHIC g22561mmi001.jpg GRAPHIC 3596
5 GRAPHIC g22561mmi002.gif GRAPHIC 5356
6 GRAPHIC g22561mmi003.jpg GRAPHIC 3598
  Complete submission text file 0001104659-12-000922.txt   109018
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 12515499
SIC: 2834 Pharmaceutical Preparations